BAYER AGBAYER AGBAYER AG

BAYER AG

No trades
See on Supercharts

Key facts today

Bayer AG has secured exclusive rights to commercialize BridgeBio Pharma's drug Attruby (acoramidis) for the treatment of ATTR-CM in Europe.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪96.99 B‬RON
−4.46RON
‪−14.65 B‬RON
‪237.33 B‬RON
‪982.40 M‬
Beta (1Y)
0.62
Employees (FY)
‪99.72 K‬
Change (1Y)
‪−1.65 K‬ −1.62%
Revenue / Employee (1Y)
‪527.25 K‬RON
Net income / Employee (1Y)
‪−32.55 K‬RON

About BAYER AG NA O.N.


CEO
William N. Anderson
Headquarters
Leverkusen
Website
Founded
1952
ISIN
DE000BAY0017
FIGI
BBG00GWY7PY4
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
M
BAYZ3875861
Monsanto Company 3.6% 15-JUL-2042
Yield to maturity
7.93%
Maturity date
Jul 15, 2042
B
US7274NBH5
BAY.US FI.II. 2064 144A
Yield to maturity
7.79%
Maturity date
Jul 15, 2064
B
BAYZ4685470
Bayer US Finance II LLC 3.95% 15-APR-2045
Yield to maturity
7.66%
Maturity date
Apr 15, 2045
M
BAYZ4140706
Monsanto Company 4.7% 15-JUL-2064
Yield to maturity
7.66%
Maturity date
Jul 15, 2064
B
BAYZ4804053
Bayer US Finance II LLC 3.6% 15-JUL-2042
Yield to maturity
7.56%
Maturity date
Jul 15, 2042
B
US7274NBG7
BAY.US FI.II. 2045 144A
Yield to maturity
7.53%
Maturity date
Apr 15, 2045
M
BAYZ4230946
Monsanto Company 3.95% 15-APR-2045
Yield to maturity
7.51%
Maturity date
Apr 15, 2045
B
BAYZ4662675
Bayer US Finance II LLC 4.4% 15-JUL-2044
Yield to maturity
7.34%
Maturity date
Jul 15, 2044
M
BAYZ4140707
Monsanto Company 4.4% 15-JUL-2044
Yield to maturity
7.30%
Maturity date
Jul 15, 2044
B
US7274NBF9
BAY.US FI.II. 2044 144A
Yield to maturity
7.30%
Maturity date
Jul 15, 2044
M
BAYZ4067527
Monsanto Company 4.65% 15-NOV-2043
Yield to maturity
7.17%
Maturity date
Nov 15, 2043

Explore more bonds 

Curated watchlists where BAYN is featured.

Frequently Asked Questions


The current price of BAYN is 100.12 RON — it has increased by 2.58% in the past 24 hours. Watch BAYER AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BVB exchange BAYER AG stocks are traded under the ticker BAYN.
BAYN stock has fallen by −1.28% compared to the previous week, the month change is a −21.90% fall, over the last year BAYER AG has showed a −39.85% decrease.
We've gathered analysts' opinions on BAYER AG future price: according to them, BAYN price has a max estimate of 184.47 RON and a min estimate of 109.68 RON. Watch BAYN chart and read a more detailed BAYER AG stock forecast: see what analysts think of BAYER AG and suggest that you do with its stocks.
BAYN reached its all-time high on Mar 20, 2015 with the price of 635.88 RON, and its all-time low was 95.53 RON and was reached on Nov 22, 2024. View more price dynamics on BAYN chart.
See other stocks reaching their highest and lowest prices.
BAYN stock is 2.55% volatile and has beta coefficient of 0.62. Track BAYER AG stock price on the chart and check out the list of the most volatile stocks — is BAYER AG there?
Today BAYER AG has the market capitalization of ‪96.99 B‬, it has decreased by −3.93% over the last week.
Yes, you can track BAYER AG financials in yearly and quarterly reports right on TradingView.
BAYER AG is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
BAYN earnings for the last quarter are 1.20 RON per share, whereas the estimation was 1.57 RON resulting in a −23.67% surprise. The estimated earnings for the next quarter are 4.90 RON per share. See more details about BAYER AG earnings.
BAYER AG revenue for the last quarter amounts to ‪49.68 B‬ RON, despite the estimated figure of ‪51.17 B‬ RON. In the next quarter, revenue is expected to reach ‪56.16 B‬ RON.
BAYN net income for the last quarter is ‪−20.85 B‬ RON, while the quarter before that showed ‪−169.30 M‬ RON of net income which accounts for ‪−12.21 K‬% change. Track more BAYER AG financial stats to get the full picture.
Yes, BAYN dividends are paid annually. The last dividend per share was 0.55 RON. As of today, Dividend Yield (TTM)% is 0.56%. Tracking BAYER AG dividends might help you take more informed decisions.
As of Nov 26, 2024, the company has ‪99.72 K‬ employees. See our rating of the largest employees — is BAYER AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAYER AG EBITDA is ‪55.38 B‬ RON, and current EBITDA margin is 25.91%. See more stats in BAYER AG financial statements.
Like other stocks, BAYN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAYER AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAYER AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAYER AG stock shows the sell signal. See more of BAYER AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.